Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Therapeutic Target for Potential Rheumatic Disease Treatment

11.10.2004


Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in “Nature Immunology.”



The chemical pathway involves the body’s responses to potent substances called cytokines which have dramatic influence on the progression, or reversal, of diseases such as rheumatoid arthritis and lupus.

Doctors have long known that cytokines can regulate diseases such as lupus, but it is now becoming appreciated that lupus can also make cytokines fail to work properly. What is not fully understood is just how the cytokines become “switched on” to cause damage. Understanding the molecular chemistry that turns on the switch becomes central to stemming disease.


The HHS in vitro and animal study work focused on the key role of interferon chemicals produced in the body as they impact cytokines production and influence inflammation. One particular kind of interferon (IFN), IFN-alpha, was believed to play a key role in lupus and is a therapeutic target for this disease. The investigators found that inflammation, as it occurs in lupus patients, changed cellular responses to IFN-alpha and made cellular response become more inflammatory and toxic.

This work supports a concept that is emerging from the laboratory of, Lionel B. Ivashkiv, M.D., lead investigator in the study at HSS published Oct 3, 2004 in “Nature Immunology.” The paper is titled “Amplification of IFN-alpha induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors.”

Specifically Dr. Ivashkiv believes that cytokine signaling is reprogrammed in patients with rheumatic diseases. This reprogramming amplifies the toxic aspects of cytokines, while compromising the effectiveness of “good cytokines” that patients produce in their bodies in an attempt to heal themselves. “We found that if we inject these IFNs in a normal mouse, there was no effect but if we injected the IFN-alpha in a mouse with lupus, we saw evidence of an influx of cells and the start of inflammation at the site where it was injected,” said Dr. Ivashkiv.

“People with rheumatic diseases like lupus and arthritis have cytokine response problems that prevent these chemicals from working properly and doing what they are supposed to do to heal the body. If we can identify and influence the chemicals that result in this and prevent it from happening, we can prevent the cycle of inflammatory response that damages these patients instead of helping them,” said Dr. Ivashkiv.

In lupus, the immune system attacks the body’s own cells and tissue, especially the skin, joints, blood, heart, lungs and kidneys. It affects 1-1.5 million Americans and is a leading cause of kidney disease, stroke and cardiovascular disease in young women.

| newswise
Further information:
http://www.hss.edu
http://www.nature.com

More articles from Health and Medicine:

nachricht Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital

nachricht New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Midwife and signpost for photons

11.12.2017 | Physics and Astronomy

How do megacities impact coastal seas? Searching for evidence in Chinese marginal seas

11.12.2017 | Earth Sciences

PhoxTroT: Optical Interconnect Technologies Revolutionized Data Centers and HPC Systems

11.12.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>